XML 61 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Combinations, Goodwill and Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2018
Business Combinations, Goodwill and Intangible Assets Disclosure [Abstract]  
Allocation of Purchase Price to Assets Acquired and Liabilities Assumed
The Company finalized its purchase price allocation for the acquisition based on their fair values as set forth below:
 
 
Amount
Tangible Assets
 
$
5,475

Liabilities
 
(5,733
)
Identifiable Intangible Assets:
 
 
        Customer relationships
 
6,760

        Developed technology
 
1,510

        Trade names and trademarks
 
570

Goodwill
 
14,229

Total purchase price
 
$
22,811

The Company’s preliminary purchase price allocation to net tangible and intangible assets of SCIO is as follows:
Assets:
 
 
Cash and cash equivalents
 
$
9,842

Restricted cash
 
2,790

Accounts receivable
 
19,924

Other current assets
 
2,076

Property and equipment
 
1,824

Other assets
 
1,751

Intangible assets
 
 
Customer relationships
 
47,800

Developed technology
 
21,400

Trade names and trademarks
 
3,700

 
 
111,107

Liabilities:
 
 
Current liabilities
 
(12,482
)
Deferred tax liabilities, net
 
(17,132
)
Other non-current liabilities
 
(200
)
 
 
(29,814
)
 
 
 
Net assets acquired
 
$
81,293

Goodwill
 
163,751

Total purchase consideration
 
$
245,044

Pro Forma Financial Information
The following unaudited pro forma results of operations have been prepared using the acquisition method of accounting to give effect to the Health Integrated acquisition as though it occurred on January 1, 2016.  The Company completed its acquisition of Health Integrated on December 22, 2017 and accordingly Health Integrated’s operations for the period from December 22, 2017 to December 31, 2017 are included in the Company’s consolidated statement of income. The pro forma amounts reflect certain adjustments, such as depreciation and amortization on assets acquired, interest expense related to liabilities not assumed by the Company and facility costs for certain facilities not acquired. The unaudited pro forma financial information is presented for illustrative purposes only, is based on purchase price allocation, and is not necessarily indicative of the results of operations that would have actually been reported had the acquisitions occurred on January 1, 2016, nor is it necessarily indicative of the future results of operations of the combined company.

 
Unaudited
 
Year ended December 31,
 
2017
 
2016
Revenues
$
801,101

 
$
729,938

Net income
$
46,998

 
$
58,232

Earnings per share:
 
 
 
Basic
$
1.39

 
$
1.73

Diluted
$
1.34

 
$
1.68

 
 
Unaudited
 
 
Year ended December 31,
 
 
2018
 
2017
Revenues, net
 
$
924,172

 
$
834,158

Net income
 
$
55,756

 
$
45,827

Earnings per share:
 
 
 
 
Basic
 
$
1.62

 
$
1.35

Diluted
 
$
1.59

 
$
1.30

Summary of Company's Goodwill
The following table sets forth details of changes in goodwill by reportable segment of the Company:

Insurance
 
Healthcare
 
TT&L
 
F&A
 
All Other
 
Analytics
 
Total
Balance as at January 1, 2017
$
38,110

 
$
19,276

 
$
12,983

 
$
47,537

 
$
5,326

 
$
63,538

 
$
186,770

Acquisitions

 
15,957

 

 

 

 

 
15,957

Currency translation adjustments
223

 

 
696

 
835

 

 

 
1,754

Balance as at December 31, 2017
$
38,333

 
$
35,233

 
$
13,679

 
$
48,372

 
$
5,326

 
$
63,538

 
$
204,481

Acquisitions

 

 

 

 

 
163,751

 
163,751

Measurement period adjustments*

 
(1,728
)
 

 

 

 

 
(1,728
)
Currency translation adjustments
(130
)
 

 
(982
)
 
(1,179
)
 

 

 
(2,291
)
Impairment charges

 
(14,229
)
 

 

 

 

 
(14,229
)
Balance as at December 31, 2018
$
38,203

 
$
19,276

 
$
12,697

 
$
47,193

 
$
5,326

 
$
227,289

 
$
349,984


* Subsequent to the date of acquisition and upon receipt of additional information, adjustments of $1,728 have been made to the Health Integrated amounts of net tangible assets acquired and the earn-out with the corresponding offset to goodwill. These adjustments are within the measurement period and would be accounted for prospectively. These adjustments did not have a significant impact on the Company’s consolidated statements of income, balance sheets or cash flows.
Schedule of Finite-Lived Intangible Assets
Information regarding the Company’s intangible assets is set forth below:
 
As of December 31, 2018
 
Gross
Carrying Amount
 
Accumulated
Amortization
 
Accumulated Impairment
 
Net Carrying
Amount
Finite-lived intangible assets:
 
 
 
 
 
 
 
Customer relationships
$
129,790

 
$
(56,367
)
 
$
(5,549
)
 
$
67,874

Leasehold benefits
2,644

 
(2,567
)
 

 
77

Developed technology
37,154

 
(14,653
)
 

 
22,501

Non-compete agreements
2,045

 
(1,937
)
 

 
108

Trade names and trademarks
9,639

 
(5,326
)
 
(278
)
 
4,035

 
$
181,272

 
$
(80,850
)
 
$
(5,827
)
 
$
94,595

Indefinite-lived intangible assets:
 
 
 
 
 
 
 
Trade names and trademarks
$
900

 
$

 
$

 
$
900

Total intangible assets
$
182,172

 
$
(80,850
)
 
$
(5,827
)
 
$
95,495

 

 
As of December 31, 2017
 
Gross
Carrying Amount
 
Accumulated
Amortization
 
Accumulated Impairment
 
Net Carrying
Amount
Finite-lived intangible assets:
 
 
 
 
 
 
 
Customer relationships
$
82,165

 
$
(43,667
)
 
$

 
$
38,498

Leasehold benefits
2,888

 
(2,596
)
 

 
292

Developed technology
15,835

 
(8,749
)
 

 
7,086

Non-compete agreements
2,045

 
(1,780
)
 

 
265

Trade names and trademarks
5,951

 
(4,034
)
 

 
1,917

 
$
108,884

 
$
(60,826
)
 
$

 
$
48,058

Indefinite-lived intangible assets:
 
 
 
 
 
 
 
Trade names and trademarks
$
900

 
$

 
$

 
$
900

Total intangible assets
$
109,784

 
$
(60,826
)
 
$

 
$
48,958

The remaining weighted average life of intangible assets is as follows:
 
(in years)
Customer relationships
7.93
Leasehold benefits
0.41
Developed technology
4.34
Non-compete agreements
0.72
Trade names and trademarks (Finite lived)
3.11
Schedule of Indefinite-Lived Intangible Assets
Information regarding the Company’s intangible assets is set forth below:
 
As of December 31, 2018
 
Gross
Carrying Amount
 
Accumulated
Amortization
 
Accumulated Impairment
 
Net Carrying
Amount
Finite-lived intangible assets:
 
 
 
 
 
 
 
Customer relationships
$
129,790

 
$
(56,367
)
 
$
(5,549
)
 
$
67,874

Leasehold benefits
2,644

 
(2,567
)
 

 
77

Developed technology
37,154

 
(14,653
)
 

 
22,501

Non-compete agreements
2,045

 
(1,937
)
 

 
108

Trade names and trademarks
9,639

 
(5,326
)
 
(278
)
 
4,035

 
$
181,272

 
$
(80,850
)
 
$
(5,827
)
 
$
94,595

Indefinite-lived intangible assets:
 
 
 
 
 
 
 
Trade names and trademarks
$
900

 
$

 
$

 
$
900

Total intangible assets
$
182,172

 
$
(80,850
)
 
$
(5,827
)
 
$
95,495

 

 
As of December 31, 2017
 
Gross
Carrying Amount
 
Accumulated
Amortization
 
Accumulated Impairment
 
Net Carrying
Amount
Finite-lived intangible assets:
 
 
 
 
 
 
 
Customer relationships
$
82,165

 
$
(43,667
)
 
$

 
$
38,498

Leasehold benefits
2,888

 
(2,596
)
 

 
292

Developed technology
15,835

 
(8,749
)
 

 
7,086

Non-compete agreements
2,045

 
(1,780
)
 

 
265

Trade names and trademarks
5,951

 
(4,034
)
 

 
1,917

 
$
108,884

 
$
(60,826
)
 
$

 
$
48,058

Indefinite-lived intangible assets:
 
 
 
 
 
 
 
Trade names and trademarks
$
900

 
$

 
$

 
$
900

Total intangible assets
$
109,784

 
$
(60,826
)
 
$

 
$
48,958

Amortization of Intangible Assets
The amortization expense for the year is as follows:
 
Year ended December 31,
 
2018
 
2017
 
2016
Amortization expense
$
20,377

 
$
13,975

 
$
11,873

Estimated Future Amortization of Intangible Assets

Estimated future amortization expense related to intangible assets as of December 31, 2018 is as follows:
2019
$
21,543

2020
14,442

2021
12,743

2022
11,331

2023
9,042

2024 and thereafter
25,494

Total
$
94,595